Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021
出 版 商：MarketsandMarkets
出版日期：2017/03/17
頁 數：129頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
The blood flow measurement devices market is projected to reach USD 533.0 million by 2021 from USD 343.6 million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021).
The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, the influx of VC funding, and technological advancements. However, the dearth of skilled professionals is limiting the growth of the global blood flow measurement devices market.
The global blood flow measurement devices market is segmented on the basis of product, application, and region. In 2016, North America accounted for the largest share of the global blood flow measurement devices market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. Factors such as the growing focus of industry players in the region, increasing geriatric population, and growing prevalence of non-communicable diseases are likely to propel the market in the Asia-Pacific region.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, product extensions, product enhancements; collaborations/agreements/partnerships/joint ventures/contracts, fund, technology development, patent, and expansions) to increase their market shares and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.
By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
By Designation: Director Level: 58%, C-level: 25%, Others: 17%
By Region: North America: 46%, Europe: 31%, APAC: 15%, RoW: 8%
The prominent players in the global blood flow measurement devices market were Compumedics Ltd. (Australia), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Deltex Medical Group plc (U.K.), ADInstruments (Australia), Perimed AB (Sweden), BIOPAC Systems, Inc. (U.S.), Moor Instruments Ltd. (U.K.), SONOTEC Ultraschallsensorik Halle GmbH (Germany), and Atys Medical (France).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the products offered by top players in the blood flow measurement devices market. The report analyzes the blood flow measurement devices by product and application
‧ Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the blood flow measurement devices market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for blood flow measurement devices across regions
‧ Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the blood flow measurement devices market
‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the blood flow measurement devices market
The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, the influx of VC funding, and technological advancements. However, the dearth of skilled professionals is limiting the growth of the global blood flow measurement devices market.
The global blood flow measurement devices market is segmented on the basis of product, application, and region. In 2016, North America accounted for the largest share of the global blood flow measurement devices market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. Factors such as the growing focus of industry players in the region, increasing geriatric population, and growing prevalence of non-communicable diseases are likely to propel the market in the Asia-Pacific region.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, product extensions, product enhancements; collaborations/agreements/partnerships/joint ventures/contracts, fund, technology development, patent, and expansions) to increase their market shares and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.
By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
By Designation: Director Level: 58%, C-level: 25%, Others: 17%
By Region: North America: 46%, Europe: 31%, APAC: 15%, RoW: 8%
The prominent players in the global blood flow measurement devices market were Compumedics Ltd. (Australia), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Deltex Medical Group plc (U.K.), ADInstruments (Australia), Perimed AB (Sweden), BIOPAC Systems, Inc. (U.S.), Moor Instruments Ltd. (U.K.), SONOTEC Ultraschallsensorik Halle GmbH (Germany), and Atys Medical (France).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the products offered by top players in the blood flow measurement devices market. The report analyzes the blood flow measurement devices by product and application
‧ Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the blood flow measurement devices market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for blood flow measurement devices across regions
‧ Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the blood flow measurement devices market
‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the blood flow measurement devices market
TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH METHODOLOGY STEPS 18
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.1.1.1 Secondary research 19
2.1.1.2 Primary research 20
2.2 MARKET SIZE ESTIMATION METHODOLOGY 23
2.3 MARKET FORECAST METHODOLOGY 25
2.4 MARKET DATA VALIDATION AND TRIANGULATION 26
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 BLOOD FLOW MEASUREMENT DEVICES: MARKET OVERVIEW 32
4.2 REGIONAL SNAPSHOT: BLOOD FLOW MEASUREMENT DEVICES MARKET,
BY PRODUCT (2016) 33
4.3 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION,
2016 VS. 2021 (USD MILLION) 33
4.4 GEOGRAPHIC SNAPSHOT OF THE GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Increasing prevalence of cardiovascular disease and diabetes coupled with rising geriatric population 37
5.2.1.2 Technological advancements 38
5.2.1.3 Influx of VC funding 38
5.2.2 RESTRAINTS 39
5.2.2.1 Development of alternative methods to treat cardiovascular diseases is restraining the market growth for transit-time flow meters 39
5.2.3 OPPORTUNITIES 39
5.2.3.1 Highly unpenetrated market for transit-time blood flow meters 39
5.2.3.2 Emerging markets across India and China 40
5.2.4 CHALLENGES 40
5.2.4.1 Dearth of skilled professionals 40
6 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY PRODUCT 41
6.1 INTRODUCTION 42
6.2 ULTRASOUND 43
6.2.1 ULTRASOUND DOPPLER 44
6.2.2 TRANSIT-TIME FLOW METERS 45
6.3 LASER DOPPLER 46
7 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION 47
7.1 INTRODUCTION 48
7.2 NON-INVASIVE APPLICATIONS 49
7.2.1 CARDIOVASCULAR DISEASE 50
7.2.2 DIABETES 51
7.2.3 GASTROENTEROLOGY 52
7.2.4 TUMOR MONITORING 52
7.2.5 OTHER NON-INVASIVE APPLICATIONS 53
7.3 INVASIVE APPLICATIONS 54
7.3.1 CABG 55
7.3.2 MICROVASCULAR SURGERY 56
7.3.3 OTHER INVASIVE APPLICATIONS 56
8 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY REGION 58
8.1 INTRODUCTION 59
8.2 NORTH AMERICA 60
8.2.1 U.S. 64
8.2.1.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of cardiovascular diseases 64
8.2.1.2 Increasing prevalence of hypertension 65
8.2.1.3 Regulatory requirements coupled with a favorable reimbursement scenario 65
8.2.1.4 Increased funding for technological advancement 65
8.2.2 CANADA 68
8.2.2.1 Technological advances 68
8.2.2.2 Increasing number of organ transplant procedures 68
?
8.3 EUROPE 71
8.3.1 EUROPE-5 74
8.3.1.1 Growing focus of industry players 74
8.3.1.2 Increasing prevalence of cancer in Europe-5 75
8.3.2 REST OF EUROPE 77
8.3.2.1 High diabetes prevalence in European countries 77
8.4 ASIA-PACIFIC 80
8.4.1 GROWING FOCUS OF INDUSTRY PLAYERS 81
8.4.2 INCREASING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN INCIDENCE OF NON-COMMUNICABLE DISEASES IN ASIA-PACIFIC 81
8.4.3 FAVORABLE REIMBURSEMENT ENVIRONMENT IN JAPAN 82
8.5 REST OF THE WORLD 84
8.5.1 LATIN AMERICA 85
8.5.2 THE MIDDLE EAST 85
8.5.3 AFRICA 86
9 COMPETITIVE LANDSCAPE 89
9.1 OVERVIEW 89
9.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BLOOD FLOW MEASUREMENT DEVICES MARKET (2013–2017) 90
9.3 COMPETITIVE SITUATION AND TRENDS 90
9.3.1 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND
PRODUCT EXTENSIONS 91
9.3.2 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES,
AND PARTNERSHIPS 92
9.3.3 EXPANSIONS 93
9.3.4 OTHER STRATEGIES 94
10 COMPANY PROFILES 95
10.1 INTRODUCTION 95
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
10.2 MEDISTIM ASA 96
10.3 COOK MEDICAL, INC. 99
10.4 GETINGE GROUP 101
10.5 DELTEX MEDICAL GROUP PLC 103
10.6 TRANSONIC SYSTEMS, INC. 105
10.7 COMPUMEDICS LIMITED 107
10.8 ADINSTRUMENTS 110
10.9 SONOTEC ULTRASCHALLSENSORIK HALLE GMBH 111
10.10 BIOPAC SYSTEMS INC. 112
10.11 MOOR INSTRUMENTS LTD. 113
10.12 ATYS MEDICAL 114
10.13 PERIMED AB 115
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
11 APPENDIX 116
11.1 DISCUSSION GUIDE 116
11.2 OTHER DEVELOPMENTS (2013–2016) 120
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 121
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 123
11.5 AVAILABLE CUSTOMIZATIONS 124
11.6 RELATED REPORTS 125
11.7 AUTHOR DETAILS 126
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH METHODOLOGY STEPS 18
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.1.1.1 Secondary research 19
2.1.1.2 Primary research 20
2.2 MARKET SIZE ESTIMATION METHODOLOGY 23
2.3 MARKET FORECAST METHODOLOGY 25
2.4 MARKET DATA VALIDATION AND TRIANGULATION 26
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 BLOOD FLOW MEASUREMENT DEVICES: MARKET OVERVIEW 32
4.2 REGIONAL SNAPSHOT: BLOOD FLOW MEASUREMENT DEVICES MARKET,
BY PRODUCT (2016) 33
4.3 GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION,
2016 VS. 2021 (USD MILLION) 33
4.4 GEOGRAPHIC SNAPSHOT OF THE GLOBAL BLOOD FLOW MEASUREMENT DEVICES MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Increasing prevalence of cardiovascular disease and diabetes coupled with rising geriatric population 37
5.2.1.2 Technological advancements 38
5.2.1.3 Influx of VC funding 38
5.2.2 RESTRAINTS 39
5.2.2.1 Development of alternative methods to treat cardiovascular diseases is restraining the market growth for transit-time flow meters 39
5.2.3 OPPORTUNITIES 39
5.2.3.1 Highly unpenetrated market for transit-time blood flow meters 39
5.2.3.2 Emerging markets across India and China 40
5.2.4 CHALLENGES 40
5.2.4.1 Dearth of skilled professionals 40
6 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY PRODUCT 41
6.1 INTRODUCTION 42
6.2 ULTRASOUND 43
6.2.1 ULTRASOUND DOPPLER 44
6.2.2 TRANSIT-TIME FLOW METERS 45
6.3 LASER DOPPLER 46
7 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY APPLICATION 47
7.1 INTRODUCTION 48
7.2 NON-INVASIVE APPLICATIONS 49
7.2.1 CARDIOVASCULAR DISEASE 50
7.2.2 DIABETES 51
7.2.3 GASTROENTEROLOGY 52
7.2.4 TUMOR MONITORING 52
7.2.5 OTHER NON-INVASIVE APPLICATIONS 53
7.3 INVASIVE APPLICATIONS 54
7.3.1 CABG 55
7.3.2 MICROVASCULAR SURGERY 56
7.3.3 OTHER INVASIVE APPLICATIONS 56
8 BLOOD FLOW MEASUREMENT DEVICES MARKET, BY REGION 58
8.1 INTRODUCTION 59
8.2 NORTH AMERICA 60
8.2.1 U.S. 64
8.2.1.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of cardiovascular diseases 64
8.2.1.2 Increasing prevalence of hypertension 65
8.2.1.3 Regulatory requirements coupled with a favorable reimbursement scenario 65
8.2.1.4 Increased funding for technological advancement 65
8.2.2 CANADA 68
8.2.2.1 Technological advances 68
8.2.2.2 Increasing number of organ transplant procedures 68
?
8.3 EUROPE 71
8.3.1 EUROPE-5 74
8.3.1.1 Growing focus of industry players 74
8.3.1.2 Increasing prevalence of cancer in Europe-5 75
8.3.2 REST OF EUROPE 77
8.3.2.1 High diabetes prevalence in European countries 77
8.4 ASIA-PACIFIC 80
8.4.1 GROWING FOCUS OF INDUSTRY PLAYERS 81
8.4.2 INCREASING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN INCIDENCE OF NON-COMMUNICABLE DISEASES IN ASIA-PACIFIC 81
8.4.3 FAVORABLE REIMBURSEMENT ENVIRONMENT IN JAPAN 82
8.5 REST OF THE WORLD 84
8.5.1 LATIN AMERICA 85
8.5.2 THE MIDDLE EAST 85
8.5.3 AFRICA 86
9 COMPETITIVE LANDSCAPE 89
9.1 OVERVIEW 89
9.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BLOOD FLOW MEASUREMENT DEVICES MARKET (2013–2017) 90
9.3 COMPETITIVE SITUATION AND TRENDS 90
9.3.1 PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND
PRODUCT EXTENSIONS 91
9.3.2 COLLABORATIONS, AGREEMENTS, CONTRACTS, JOINT VENTURES,
AND PARTNERSHIPS 92
9.3.3 EXPANSIONS 93
9.3.4 OTHER STRATEGIES 94
10 COMPANY PROFILES 95
10.1 INTRODUCTION 95
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
10.2 MEDISTIM ASA 96
10.3 COOK MEDICAL, INC. 99
10.4 GETINGE GROUP 101
10.5 DELTEX MEDICAL GROUP PLC 103
10.6 TRANSONIC SYSTEMS, INC. 105
10.7 COMPUMEDICS LIMITED 107
10.8 ADINSTRUMENTS 110
10.9 SONOTEC ULTRASCHALLSENSORIK HALLE GMBH 111
10.10 BIOPAC SYSTEMS INC. 112
10.11 MOOR INSTRUMENTS LTD. 113
10.12 ATYS MEDICAL 114
10.13 PERIMED AB 115
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
11 APPENDIX 116
11.1 DISCUSSION GUIDE 116
11.2 OTHER DEVELOPMENTS (2013–2016) 120
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 121
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 123
11.5 AVAILABLE CUSTOMIZATIONS 124
11.6 RELATED REPORTS 125
11.7 AUTHOR DETAILS 126
